Bengal Energy Ltd. Announces Election of Directors

Calgary, Alberta–(Newsfile Corp. – September 18, 2019) –  Bengal Energy Ltd. (TSX: BNG) (“Bengal“) is pleased to announce that the nominees listed in the information circular – proxy statement dated August 19, 2019 were elected as directors of Bengal. The detailed results of the vote for the election of directors held at its annual and special meeting of shareholders on September 18, 2019 in Calgary, Alberta are set out below.

Election of Directors

On a vote by ballot, each of the following seven nominees proposed by management was elected as a director of Bengal:

Votes For Votes Withheld
Ian J. Towers 41,914,910 848,521
Chayan Chakrabarty 41,919,910 843,521
Peter D. Gaffney 41,917,410 846,021
James B. Howe 41,917,410 846,021
Brian J. Moss 41,912,410 851,021
Robert D. Steele 41,912,410 851,021
W.B. (Bill) Wheeler 42,746,631 16,800


Bengal Energy Ltd.
Chayan Chakrabarty, President & Chief Executive Officer
Matthew Moorman, Chief Financial Officer
Phone: (403) 205-2526

About Bengal
Bengal Energy Ltd. is an international junior oil and gas exploration and production company with assets in Australia. Bengal is committed to growing shareholder value through international exploration, production and acquisitions. Bengal’s common shares trade on the TSX under the symbol “BNG”. Additional information is available at

To view the source version of this press release, please visit

from Newsfile Corp News Releases (WordPress)


Sienna Resources Amends Terms on Slättberg Nickel-Copper-Cobalt Project in Sweden

Vancouver, British Columbia–(Newsfile Corp. – September 18, 2019) – Sienna Resources (TSXV: SIE) (FSE: A1XCQ0) (OTC Pink: SNNAF) wishes to announce that it has amended the option date of an exploration and option agreement (the “Agreement”) with Eurasian Minerals Sweden AB, a wholly owned subsidiary of EMX Royalty Corp., originally announced on December 4, 2017, on the Slättberg Cobalt-Nickel-Copper Project in Sweden. The option date has been extended to December 31, 2019. Under the new agreement Sienna will expend at least 250,000 CAD in exploration expenditures within this new option period. All other terms of the Agreement remain the same.

The company has granted two million incentive stock options to directors, officers and consultants at an exercise price of 6.5 cents per share for a period of 12 months. The options have been granted in accordance with the company’s stock option plan.

If you would like to be added to Sienna’s email list please email for information or join our twitter account at @SiennaResources.

Contact Information
Tel: 1.604.646.6900
Fax: 1.604.689.1733

“Jason Gigliotti”
President, Director
Sienna Resources Inc.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this press release.

To view the source version of this press release, please visit

from Newsfile Corp News Releases (WordPress)

SEC Charges ICO Incubator and Founder for Unregistered Offering and Unregistered Broker Activity

Washington, D.C.–(Newsfile Corp. – September 18, 2019) – The Securities and Exchange Commission today sued ICOBox and its founder Nikolay Evdokimov for conducting an illegal $14 million securities offering of ICOBox’s digital tokens and for acting as unregistered brokers for other digital asset offerings. 

According to the SEC’s complaint, ICOBox raised funds in 2017 to develop a platform for initial coin offerings by selling, in an unregistered offering, roughly $14.6 million of “ICOS” tokens to over 2,000 investors. The complaint alleges that defendants claimed the tokens would increase in value upon trading and that ICOS token holders would be able to swap them at a discount for other tokens promoted on the ICOBox platform. According to the complaint, the ICOS tokens are virtually worthless.  The complaint further alleges that ICOBox failed to register as a broker but acted as one by facilitating initial coin offerings that raised more than $650 million for dozens of clients.

“By ignoring the registration requirements of the federal securities laws, ICOBox and Evdokimov exposed investors to investments, which are now virtually worthless, without providing information that is critical to making informed investment decisions,” said Michele Wein Layne, Regional Director of the Los Angeles Regional Office.

The SEC’s complaint charges ICOBox and Evdokimov with violating the registration requirements of the federal securities laws and seeks injunctive relief, disgorgement with prejudgment interest, and civil money penalties.

The SEC’s investigation was conducted by Brent W. Wilner and was supervised by Victoria A. Levin, Alka N. Patel, and Ms. Layne of the Los Angeles Regional Office.  The litigation is being conducted by Amy J. Longo of the Los Angeles Regional Office.

from Newsfile Corp News Releases (WordPress)

Alternate Health’s Board Welcomes Leigh Valentine

Founder of Beauty Company With $300 Million in Sales

Toronto, Ontario–(Newsfile Corp. – September 18, 2019) – Alternate Health Corp., (CSE: AHG) (OTCQB: AHGIF) (“Alternate Health” or the “Company“), an international leader in CBD product development and distribution, announced today that Leigh Valentine, internationally renowned entrepreneur beauty, has accepted a position on the Company’s Board of Directors and will work with the Company to develop a line of branded CBD beauty products.

“We are thrilled to welcome Leigh Valentine, an absolute dynamo and pioneer in health and beauty direct-selling,” says Howard Mann, CEO of Alternate Health. “With her experience building brands with hundreds of millions in sales, she is a major addition to our team as we roll out our own Leigh Valentine-branded products.”

Following the Company’s $20 million acquisition of California pharmaceutical company, Blaine Labs, Alternate Health is in a unique position to capture the CBD health and wellness market share. By combining Alternate Health’s network of physicians and Blaine Labs’ 23 years of operating experience, the Company is the one of the few, if not only, FDA-registered and cGMP-compliant CBD company with a proven track record of pharmaceutical manufacturing.

Alternate Health believes Leigh Valentine is the ideal partner to rapidly scale CBD sales and distribution, based on her loyal customer base and her expertise in direct-selling. Her company, Leigh Valentine Beauty (LVB), has sold over $300 million worth of products. Together, Alternate Health aims to repeat her success in the rapidly growing CBD industry.

“In my career, I owe my success to providing my customers with only the highest quality products,” says Leigh Valentine, founder of LVB. “With Alternate Health’s commitment to the best sourcing and manufacturing practices, we believe we can establish the most trustworthy brand in the industry.”

Leigh Valentine graduated from Stephens College with degrees in both Business Administration and Fashion Merchandising. She has served as a national beauty consultant for Revlon, Estee Lauder and Lancôme. Driven by her passion for fashion and beauty, she established her own company, Leigh Valentine Beauty (LVB), and began to formulate her own line of health and beauty products.

In 2000, she launched sales of her products, with direct selling as the centerpiece of her marketing strategy. This included infomercials on the QVC network, where her proprietary product Fermalift became the number one beauty infomercial in the country, running for over eight years. She first appeared on QVC in 2001 and was seen on the channel for the next 12 years with over 500 live shows. Between infomercials and QVC exposure, over $300 million worth of her products have been sold in the U.S. and Canada.

“Alternate Health is privileged to work with Leigh to achieve our shared goal of helping men and women regain and maintain a healthy, youthful look with renewed self-confidence,” says Howard Mann, CEO of Alternate Health. “The introduction of the new line of Valentine products has been eagerly anticipated. Her grace, goodwill and success are an inspiration to all.”

Amended Financing Agreement

Alternate Health would also like to announce that the Company and European High Growth Opportunities Securitization Fund (the “Fund“) have further amended and restated the amended and restated subscription agreement dated July 3, 2019 (as further amended and restated, the “Agreement“), relating to a financing facility the Company announced in news releases on June 14, 2019 and July 17, 2019 respectively. Pursuant to the Agreement, the Company and the Fund have agreed to reduce the subscription amount provided for in the Agreement from $5,000,000 to $1,850,000, of which $700,000 has already been funded. To date, the Fund has converted $510,000 of the debenture previously issued to it by the Company, with Alternate Health issuing a total of 1,757,618 common shares to the Fund as a result of such conversions. A copy of the Agreement is posted on SEDAR.

About Alternate Health

Alternate Health is an international leader in the hemp-derived CBD industry, including extraction, product development and distribution. Through Alternate Health’s subsidiary, Blaine Labs, the Company has 23 years of experience in FDA-registered and cGMP medical product manufacturing and distribution, with over 50 product SKUs available from major retailers, including Walmart, Amazon, CVS and Walgreens. Alternate Health’s innovative software systems provide the platform for the company’s diverse operations, including CBD product distribution, hemp-derived extract manufacturing, blockchain tax collection systems and electronic medical records (EMR) platforms. For more information about Alternate Health Corp., visit

Investor Contact

Jim Griffiths | Investor Relations

Jim Tykoliz | Company Director


Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE) accepts responsibility for the adequacy or accuracy of this release. Statements included in this announcement, including statements concerning our plans, intentions and expectations, including with respect to the closing of the letter of intent, which are not historical in nature are intended to be, and are hereby identified as “forward-looking statements”. Forward-looking statements may be identified by words including “anticipates”, “believes”, “intends”, “estimates”, “expects” and similar expressions. The Company cautions readers that forward-looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the forward-looking statements.

To view the source version of this press release, please visit

from Newsfile Corp News Releases (WordPress)

Khiron CEO Alvaro Torres Talks Trailblazing in Colombia and Expanding Operations

Toronto, Ontario–(Newsfile Corp. – September 18, 2019) – Capital 10X President Evan Veryard sits down with Khiron Life Sciences (TSXV: KHRN) CEO Alvaro Torres.

They discuss Khiron’s Colombian operations, expansion plans, and whether Khiron is on track to meet analyst expectations.

Cannot view this video? Visit:

For more information, please contact:

Capital 10X
Evan Veryard, President

To view the source version of this press release, please visit

from Newsfile Corp News Releases (WordPress)

Interlapse Technologies Corp. Invites You to Join Us at the XFuture Conference in Vancouver

Vancouver, British Columbia–(Newsfile Corp. – September 18, 2019) – Interlapse Technologies Corp. (TSXV: INLA) would like to cordially invite you to visit us at Booth #502 at the Extraordinary Future Conference (XFuture) to be held at the Vancouver Convention Centre West (1055 Canada Place, Vancouver) on Sunday September 22 – Monday September 23, 2019.

The Extraordinary Future conference drives innovation in Canada by connecting technology companies with capital. Whether you are a tech company looking to get a better understanding of investment opportunities or you are a business savvy investor looking for the next big thing, there is no other conference in Vancouver that is like Extraordinary Future.

For more information and/or to register for the conference please visit: Use the promo code FUTURE30 for 30% off your ticket.

We look forward to seeing you there.

For further information:

Interlapse Technologies Corp.
Ashley Garnot

from Newsfile Corp News Releases (WordPress)

SEC Halts Alleged $125 Million Offering Fraud

Washington, D.C.–(Newsfile Corp. – September 18, 2019) – The Securities and Exchange Commission today announced that it has filed an emergency action and obtained a temporary restraining order and asset freeze against three individuals and three entities in connection with an alleged fraudulent, ongoing international trading program that has placed at risk more than $125 million of investor funds.

According to the SEC’s complaint, beginning in March 2016, Mediatrix Capital Inc. and its three principals, Michael S. Young, Michael S. Stewart, and Bryant E. Sewall, induced investors to invest by falsely representing that their money would be invested using a highly profitable algorithmic trading strategy that had never experienced an unprofitable month and had returned more than 1,600% since inception. In truth, the complaint alleges, the defendants’ trading strategy consistently lost money—losing more than $18 million from its trading in 2018 alone. In addition to repeatedly misrepresenting the profitability of the trading, the complaint alleges defendants also misled investors by falsifying account statements and making Ponzi-like payments, all while misappropriating more than $35 million of investor money for defendants’ personal use, including to purchase luxury properties and vehicles.

“We allege that this scheme has resulted in tens of millions of dollars in investor losses, in part, to fund defendants’ luxurious lifestyle,” said Kurt L. Gottschall, Director of the SEC’s Denver Regional Office. “The SEC will do all it can to hold these defendants accountable and ensure money is returned to those who were deceived.”

The SEC’s complaint, filed in federal district court in Colorado on Sept. 12, 2019, and unsealed today, charges all defendants with violating the antifraud provisions of Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder, and Section 17(a) of the Securities Act of 1933, as well as with violating the registration provisions of Section 5(a) and 5(c) of the Securities Act. The SEC’s complaint also charges Mediatrix Capital, Young, Stewart, and Sewall with violations of the antifraud provisions of the Investment Advisers Act of 1940. The SEC has also charged 20 relief defendants who allegedly received profits from the fraud.

The SEC’s continuing investigation is being conducted by Jeffrey D. Felder and Tracy W. Bowen of the SEC’s Denver Regional Office and supervised by Kimberly L. Frederick and Jason J. Burt. The litigation is being led by Stephen C. McKenna and Mark D. Williams and supervised by Gregory A. Kasper. The SEC appreciates the assistance of the U.S. Commodity Futures Trading Commission, the U.S. Attorney’s Office for the District of Colorado, the Federal Bureau of Investigation, and the U.S. Marshals Service. The SEC also appreciates the assistance of the U.K. Financial Conduct Authority,the Czech National Bank, the New Zealand Financial Markets Authority, the Securities Commission of The Bahamas, the Central Bank of Armenia, and the Cayman Islands Monetary Authority.

from Newsfile Corp News Releases (WordPress)